Gilead Sciences to Present at the RBC Capital Markets 2017 Global Healthcare Conference on Wednesday, February 22

Wednesday, 8 February 2017  (2 weeks ago)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that John F. Milligan, PhD, Gilead’s President and Chief Executive Officer, and Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the RBC Capital Markets 2017 Global Healthcare Conference in New York on Wednesday, February 22 at 9:30 a.m. Eastern Time. The audio portion of the fireside chat will be accessible live through the company’

Recent related news

Advertisement
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (Nasdaq: AERI), a clinical-stage pharmaceutical company focused on the discovery, development and...
1 week ago • Business Wire
STAMFORD, Conn.--(BUSINESS WIRE)--United Rentals, Inc. (NYSE: URI) today announced that it will participate in the Barclays Industrial Select Conference on...
1 week ago • Business Wire
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the RBC Capital Markets...
6 days ago • Business Wire
BRENTWOOD, Tenn.--(BUSINESS WIRE)--LifePoint Health, Inc. (NASDAQ: LPNT) today announced that its management will participate in the RBC Capital Markets 2017...
1 week ago • Business Wire
DULUTH, Ga.--(BUSINESS WIRE)--AGCO, Your Agriculture Company (NYSE:AGCO), a worldwide manufacturer and distributor of agricultural equipment and infrastructure,...
2 days ago • Business Wire
PARIS--(BUSINESS WIRE)--Regulatory News: ABIVAX (Paris:ABVX) (Euronext Paris: FR0012333284 – ABVX), an innovative biotechnology company targeting the immune...
1 week ago • Business Wire

You might like